Palouse Capital Management, Inc. Pfizer Inc Transaction History

Palouse Capital Management, Inc.

$154 Million
Q3 2024

A detailed history of Palouse Capital Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Palouse Capital Management, Inc. holds 146,513 shares of PFE stock, worth $3.92 Million. This represents 2.75% of its overall portfolio holdings.

Number of Shares

146,513

Previous 146,513 -0.0%

Holding current value

$3.92 Million

Previous $4.24 Million -0.0%

% of portfolio

2.75%

Previous 2.75%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$27.7 - $31.39 $76,064 - $86,196	-2,746 Reduced 1.84%	146,513 $4.24 Million
Q2 2024 Aug 12, 2024	SELL	$25.26 - $29.6 $64,261 - $75,302	-2,544 Reduced 1.68%	149,259 $4.18 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $136,517 - $156,766	-5,273 Reduced 3.36%	151,803 $4.21 Million
Q4 2023 Jan 31, 2024	BUY	$26.13 - $33.94 $1.5 Million - $1.95 Million	57,476 Added 57.71%	157,076 $4.52 Million
Q3 2023 Oct 23, 2023	SELL	$32.09 - $37.51 $40,497 - $47,337	-1,262 Reduced 1.25%	99,600 $3.3 Million
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $311,968 - $360,940	8,637 Added 9.37%	100,862 $3.7 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $979,550 - $1.28 Million	24,868 Added 36.92%	92,225 $3.76 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $180,652 - $235,821	-4,327 Reduced 6.04%	67,357 $3.45 Million
Q3 2022 Oct 21, 2022	SELL	$43.76 - $53.42 $1.08 Million - $1.32 Million	-24,783 Reduced 25.69%	71,684 $3.14 Million
Q2 2022 Jul 28, 2022	SELL	$46.53 - $55.17 $5,909 - $7,006	-127 Reduced 0.13%	96,467 $5.06 Million
Q1 2022 Apr 21, 2022	SELL	$45.75 - $56.69 $52,749 - $65,363	-1,153 Reduced 1.18%	96,594 $5 Million
Q4 2021 Jan 25, 2022	SELL	$41.32 - $61.25 $110,076 - $163,170	-2,664 Reduced 2.65%	97,747 $5.77 Million
Q3 2021 Oct 21, 2021	SELL	$39.25 - $50.42 $80,776 - $103,764	-2,058 Reduced 2.01%	100,411 $4.32 Million
Q2 2021 Jul 28, 2021	SELL	$35.91 - $40.68 $42,553 - $48,205	-1,185 Reduced 1.14%	102,469 $4.01 Million
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $3.47 Million - $3.92 Million	103,654 New	103,654 $3.76 Million
Q3 2018 Oct 29, 2018	SELL	$34.47 - $41.81 $7.9 Million - $9.58 Million	-229,163 Closed	0 $0
Q2 2018 Jul 27, 2018	SELL	$32.98 - $35.16 $159,656 - $170,209	-4,841 Reduced 2.07%	229,163 $8.31 Million
Q1 2018 May 04, 2018	SELL	$31.91 - $37.02 $142,190 - $164,961	-4,456 Reduced 1.87%	234,004 $8.31 Million
Q4 2017 Feb 05, 2018	SELL	$33.26 - $35.29 $40,643 - $43,124	-1,222 Reduced 0.51%	238,460 $8.64 Million
Q3 2017 Oct 30, 2017	BUY	$31.0 - $34.15 $7.43 Million - $8.19 Million	239,682	239,682 $8.56 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Palouse Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Palouse Capital Management, Inc. with notifications on news.

Account

Palouse Capital Management, Inc. Pfizer Inc Transaction History